Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboxane A2 and platelet-activating factor decrease in the platelet-mesangial cell interactions

I Arribas1, D Rodríguez-Puyol, M C García-Escribano

  • 1Clinical Chemistry Department University Hospital Príncipe de Asturias, Madrid, Spain.

Life Sciences
|January 1, 1995
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B-cell acute lymphoblastic leukemia after lenalidomide maintenance therapy; a deleterious adverse event that needs further investigation. Report of three cases and review of the literature.

Leukemia & lymphoma·2023
Same author

The integrin beta1 modulator Tirofiban prevents adipogenesis and obesity by the overexpression of integrin-linked kinase: a pre-clinical approach in vitro and in vivo.

Cell & bioscience·2022
Same author

[Management of a first depressive episode in the primary care setting. Use of antidepressants and referrals].

Semergen·2015
Same author

Outcome of acute renal injury in diabetic mice with experimental endotoxemia: role of hypoxia-inducible factor-1 α.

Journal of diabetes research·2013
Same author

Integrin-linked kinase mediates the hydrogen peroxide-dependent transforming growth factor-β1 up-regulation.

Free radical biology & medicine·2013
Same author

Effectiveness of a diagnostic algorithm combining clinical probability, D-dimer testing, and computed tomography in patients with suspected pulmonary embolism in an emergency department.

Romanian journal of internal medicine = Revue roumaine de medecine interne·2013

Mesangial cells (MC) reduce platelet-activating factor (PAF) and Thromboxane A2 (TxA2) levels. This study suggests MC specifically affect platelet metabolism of these key signaling molecules.

Area of Science:

  • Nephrology
  • Immunology
  • Biochemistry

Background:

  • Platelet-activating factor (PAF) and Thromboxane A2 (TxA2) are key mediators in platelet function and inflammatory responses.
  • Mesangial cells (MC) play a crucial role in kidney physiology and pathology, interacting with various blood components.
  • Understanding the interplay between platelets and MC is vital for elucidating kidney disease mechanisms.

Purpose of the Study:

  • To investigate the metabolic fate of platelet-activating factor (PAF) and Thromboxane A2 (TxA2) during platelet-mesangial cell (MC) interactions.
  • To determine if MC influence the synthesis or degradation of PAF and TxA2 produced by platelets.
  • To assess the intrinsic PAF synthesis by MC and its modulation by platelet-derived factors.

Main Methods:

Related Experiment Videos

  • Cultured rat MC were incubated with platelets (P) or platelet supernatants (PS).
  • Immunoreactive thromboxane B2 (TxB2) and PAF levels were quantified.
  • Intrinsic MC synthesis of PAF was assessed using [3H]-acetate incorporation and HPLC analysis.

    • Main Results:

    • TxB2 levels significantly decreased when MC were incubated with platelets or platelet supernatants, indicating enhanced degradation or MC-specific effects.
    • PAF levels showed a similar decrease, mirroring the TxB2 findings.
    • Platelets or platelet supernatants did not alter the intrinsic PAF synthesis by MC.

    Conclusions:

    • Mesangial cells exert a specific influence on platelet-derived Thromboxane A2 (TxA2) metabolism.
    • Mesangial cells also specifically affect platelet-activating factor (PAF) metabolism.
    • These findings highlight a novel interaction pathway between MC and platelets relevant to renal function and disease.